Association of prescription drug monitoring programs with benzodiazepine prescription dispensation and overdose in adolescents and young adults

被引:1
|
作者
Toce, Michael S. S. [1 ,2 ,3 ,6 ]
Michelson, Kenneth A. A. [1 ,3 ]
Hudgins, Joel D. D. [1 ,3 ]
Olson, Karen L. L. [3 ,4 ]
Monuteaux, Michael C. C. [1 ]
Bourgeois, Florence T. T. [1 ,3 ,5 ]
机构
[1] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Harvard Med Toxicol Program, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Pediat, Boston, MA USA
[4] Boston Childrens Hosp, Computat Hlth Informat Program CHIP, Boston, MA 02115 USA
[5] Boston Childrens Hosp, Computat Hlth Informat Program CHIP, Pediat Therapeut & Regulatory Sci Initiat, Boston, MA 02115 USA
[6] Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA
关键词
Benzodiazepine; overdose; prescription drug misuse; adolescents; prescription drug monitoring program; STATES; REDUCE; LAWS;
D O I
10.1080/15563650.2023.2181092
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
IntroductionPrescription drug monitoring programs are state-run databases designed to support safe prescribing of controlled substances and reduce prescription drug misuse. We analyzed healthcare claims data to determine the association between prescription drug monitoring programs with mandated provider review and adolescent and young adult benzodiazepine prescription dispensing and overdose.MethodsWe performed a state-level retrospective cohort study to evaluate the association between implementation of prescription drug monitoring programs with mandated provider review and benzodiazepine prescription dispensing and benzodiazepine-related overdoses among adolescents (13-18 years) and young adults (19-25 years) between 1 January 2008 and 31 December 2019. Data were obtained from a United States commercial health insurance company.ResultsThere were 74,539 (1.8%) adolescents and 246,760 (4.0%) young adults with at least one benzodiazepine prescription dispensed. Benzodiazepine overdoses occurred among 1,569 (0.04%) and 3,202 (0.05%) adolescents and young adults, respectively. Implementation of a prescription drug monitoring program with mandated provider review was associated with a 6.8% (95% CI, 1.6-11.8) yearly reduction in benzodiazepine prescription dispensing among adolescents and a 12.5% (95% CI, 9.3-15.5) yearly reduction among young adults. There was no decrease in benzodiazepine overdoses in either age group (-15.4% [95% CI, -21.5 to 3.0] and -8.0% [95% CI, -18.0 to 3.2] yearly change in adolescents and young adults, respectively).DiscussionConsistent with prior work, our study did not find an association between prescription drug monitoring program implementation and reduction in benzodiazepine-related overdoses among adolescents and young adults. However, the substantial reduction in benzodiazepine prescription dispensing is encouraging.ConclusionPrescription drug monitoring programs were associated with decreases in benzodiazepine prescription dispensing, but not benzodiazepine-related overdoses in this cohort of adolescents and young adults. These findings serve to inform development of further policies to address rising rates of benzodiazepine misuse and overdose in this patient population.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 50 条
  • [41] Prescription Drug Monitoring Programs and Opioid Death Rates
    Rudman, William, Jr.
    Corcoran, Peter
    Elliot, Kimberly
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (20): : 2044 - 2044
  • [42] Trends in prescription drug misuse sources: demographic differences among adolescents and young adults
    Purser, Gregory Larkin
    Munroe, Leah A.
    JOURNAL OF SUBSTANCE USE, 2024, 29 (05) : 892 - 898
  • [43] Revisiting Paulozzi et al.'s "Prescription Drug Monitoring Programs and Death Rates from Drug Overdose"
    Green, Traci C.
    Zaller, Nickolas
    Rich, Josiah
    Bowman, Sarah
    Friedmann, Peter
    PAIN MEDICINE, 2011, 12 (06) : 982 - 985
  • [44] PRESCRIPTION DRUG OVERDOSE IN THE STATE OF TEXAS
    Lobo, N.
    Dihowm, F.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 743 - 744
  • [45] Prescription Drug Monitoring and Dispensing of Prescription Opioids
    Brady, Joanne E.
    Wunsch, Hannah
    DiMaggio, Charles
    Lang, Barbara H.
    Giglio, James
    Li, Guohua
    PUBLIC HEALTH REPORTS, 2014, 129 (02) : 139 - 147
  • [46] An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions
    Islam, M. Mofizul
    McRae, Ian S.
    BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
  • [47] An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions
    M Mofizul Islam
    Ian S McRae
    BMC Pharmacology and Toxicology, 15
  • [48] Overdose Epidemic, Prescription Monitoring Programs, and Public Health: A Review of State Laws
    Davis, Corey S.
    Johnston, Jill E.
    Pierce, Matthew W.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (11) : E9 - E11
  • [49] PRESCRIPTION MONITORING PROGRAMS' UTILIZATION
    Fleming, M. L.
    Barner, J. C.
    Chandwani, H.
    Okoro, T.
    Weber, S.
    VALUE IN HEALTH, 2011, 14 (03) : A68 - A68
  • [50] The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare
    Buchmueller, Thomas C.
    Carey, Colleen
    AMERICAN ECONOMIC JOURNAL-ECONOMIC POLICY, 2018, 10 (01) : 77 - 112